Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Rheumatoid Arthritis (RA) of more than 6 months and less than 15 years
Regular use of methotrexate (MTX) in the past 12 weeks, with the dose being stable during the past 8 weeks
At least 8 tender and swollen joints
At least one erosion of a hand or foot joint observed on an X-ray
An abnormally high C-reactive protein (CRP) level or erythrocyte sedimentation rate (ESR)
Positive for rheumatoid factor (RF) or anti-cyclic citrullinated peptide (CCP) antibody
Woman must not be pregnant, breastfeeding, or become pregnant during the study
You may not be if
Use of unstable doses of non-steroidal anti-inflammatory drugs (NSAIDS) in the past 6 weeks
Steroid injection or intravenous (iv) infusion in the last 6 weeks
Use of more than 10 milligrams/day (mg/day) of oral steroids in the last 6 weeks
History of an inadequate response to a biologic disease-modifying anti-rheumatic drug (DMARD)
History of a serious reaction to other biological DMARDs
History of the use of rituximab or other B cell therapy
Use of DMARDS other than MTX, hydroxychloroquine, or sulfasalazine within the last 8 weeks
Use of leflunomide within the last 12 weeks (unless cholestyramine was used to speed up the elimination of leflunomide)
Surgery on a joint or other major surgery less than 2 months ago, or plans to have joint surgery or major surgery during the study
Active fibromyalgia, juvenile chronic arthritis, spondyloarthropathy, Crohn's disease, ulcerative colitis, psoriatic arthritis, or other systemic inflammatory condition except RA
Cervical cancer or squamous skin cancer within the past 3 years, or other cancer within the past 5 years
Received a live vaccine received within the past 12 weeks (for example, vaccines for measles, mumps, rubella, and chicken pox, and nasal-spray flu vaccines)
Hepatitis or human immunodeficiency virus (HIV)
A serious bacterial infection (for example, pneumonia or cellulitis) within 3 months or a serious bone or joint infection within 6 months
Symptoms of herpes zoster or herpes simplex within the last month
Active or latent tuberculosis (TB)
Current symptoms of a serious disorder or illness
Use of an investigational drug within the last month
History of the use of rituximab, any other B cell targeted biotherapy, or denosumab